| Aha SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher, RS Blumenthal, ... ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the …, 2018 | 6607 | 2018 |
| 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart … SM Grundy, NJ Stone, AL Bailey, C Beam, KK Birtcher, RS Blumenthal, ... Circulation 139 (25), e1082-e1143, 2019 | 5259* | 2019 |
| Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific … BS Wiggins, JJ Saseen, RL Page, BN Reed, K Sneed, JB Kostis, ... Circulation 134 (21), e468-e495, 2016 | 274 | 2016 |
| American College of Clinical Pharmacy's vision of the future: postgraduate pharmacy residency training as a prerequisite for direct patient care practice JE Murphy, JM Nappi, JA Bosso, JJ Saseen, BA Hemstreet, MA Halloran, ... Pharmacotherapy 26 (5), 722-733, 2006 | 274 | 2006 |
| Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension BM Mehos, JJ Saseen, EJ MacLaughlin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (11 …, 2000 | 236 | 2000 |
| Patient-level medication regimen complexity across populations with chronic disease AM Libby, DN Fish, PW Hosokawa, SA Linnebur, KR Metz, KV Nair, ... Clinical therapeutics 35 (4), 385-398. e1, 2013 | 215 | 2013 |
| ACCP clinical pharmacist competencies JJ Saseen, TL Ripley, D Bondi, JM Burke, LJ Cohen, S McBane, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 37 (5 …, 2017 | 195 | 2017 |
| Costs of {beta}-Lactam Allergies: Selection and Costs of Antibiotics for Patients With a Reported {beta}-Lactam Allergy EJ MacLaughlin, JJ Saseen, DC Malone Archives of family medicine 9 (8), 722, 2000 | 183 | 2000 |
| Hypertension JJ Saseen, EJ MacLaughlin Pharmacotherapy: A Pathophysiologic Approach. 6th ed. New York: McGraw-Hill …, 2005 | 153 | 2005 |
| β-blockers: a review of their pharmacological and physiological diversity in hypertension TL Ripley, JJ Saseen Annals of Pharmacotherapy 48 (6), 723-733, 2014 | 130 | 2014 |
| A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions PW Sullivan, R Valuck, J Saseen, HM MacFall CNS drugs 18, 911-932, 2004 | 118 | 2004 |
| Gouty arthritis: a review of acute management and prevention L Wilson, JJ Saseen Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (8 …, 2016 | 117 | 2016 |
| Update on the use of PCSK9 inhibitors in adults: Recommendations from an Expert Panel of the National Lipid Association CE Orringer, TA Jacobson, JJ Saseen, AS Brown, AM Gotto, JL Ross, ... Journal of clinical lipidology 11 (4), 880-890, 2017 | 115 | 2017 |
| Role of bempedoic acid in clinical practice CM Ballantyne, H Bays, AL Catapano, A Goldberg, KK Ray, JJ Saseen Cardiovascular Drugs and Therapy 35 (4), 853-864, 2021 | 111 | 2021 |
| Comparison of nifedipine alone and with diltiazem or verapamil in hypertension JJ Saseen, BL Carter, TER Brown, WJ Elliott, HR Black Hypertension 28 (1), 109-114, 1996 | 111 | 1996 |
| Understanding barriers to medication adherence in the hypertensive population by evaluating responses to a telephone survey KV Nair, DA Belletti, JJ Doyle, RR Allen, RB McQueen, JJ Saseen, ... Patient preference and adherence, 195-206, 2011 | 106 | 2011 |
| Randomized, placebo‐controlled trial of oral phytonadione for excessive anticoagulation RJ Patel, DM Witt, JJ Saseen, DJ Tillman, DS Wilkinson Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (10 …, 2000 | 101 | 2000 |
| Trends in antihypertensive medication monotherapy and combination use among US adults, National Health and Nutrition Examination Survey 2005–2016 CG Derington, JB King, JS Herrick, D Shimbo, IM Kronish, JJ Saseen, ... Hypertension 75 (4), 973-981, 2020 | 98 | 2020 |
| Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents MR Hanselin, JJ Saseen, RR Allen, JC Marrs, KV Nair Hypertension 58 (6), 1008-1013, 2011 | 94 | 2011 |
| NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient MK Cheeley, JJ Saseen, A Agarwala, S Ravilla, N Ciffone, TA Jacobson, ... Journal of Clinical Lipidology 16 (4), 361-375, 2022 | 82 | 2022 |
